Federal Reserve's Shifting Sands: How Robust Data Reshaped Market Expectations and Sent Stocks Tumbling

Kenvue Stock Under Siege: Trump's Tylenol Warning Rekindles Autism Lawsuits, But Retail Bulls Hold Firm

Kenvue's Remarkable Rebound: Shaking Off White House Pressure and Soaring Back

GSK Advances Endometrial Cancer Treatment Protocols, Seeking Leucovorin Label Update for Jemperli

Kenvue's Remarkable Ascent: From Record Lows to Market Momentum

Kenvue Stock Plummets Amid Tylenol Autism Lawsuit & Trump's Fiery Call to Arms

Market Movers: Decoding Final Trades for Apple, Citi, Pfizer, and Kenvue Ahead

Groundbreaking Report: Trump Administration Formally Connects Prenatal Tylenol Use to Autism and ADHD Concerns

Kenvue Fights Back: Tylenol Maker Confronts Autism Allegations Ahead of Landmark Government Report

Kenvue Explores 'Learned Intermediary' Defense Amidst Thousands of Tylenol-Autism Lawsuits

Kenvue's Tylenol Turmoil: RFK Jr.'s Autism Report Sends Stock Reeling Amidst Scientific and Legal Battles